Format

Send to

Choose Destination
Br J Haematol. 2012 Mar;156(5):559-72. doi: 10.1111/j.1365-2141.2011.08988.x. Epub 2011 Dec 22.

Management of multidrug-resistant viruses in the immunocompromised host.

Author information

1
Department of Haematology, University College London Cancer Institute, 72 Huntley Street, London WC1E 6DD, UK. k.peggs@cancer.ucl.ac.uk

Abstract

Multidrug-resistant viruses remain a clinically challenging complication in the immunocompromised host. This review discusses mechanisms of viral resistance and treatment options in this context with particular emphasis on the immunocompromised haematology patient. We also outline some of the newer agents and treatment strategies being developed to treat multidrug-resistant viruses.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center